Explain the process of immunosuppression and the effect it has on body systems.
Three questions, and the middle one is where the marks are lost. The genes asked about are the patient's, not the fungus's, and the immunosuppression has two separate mechanisms because he is on two different drugs.
Editorial process
Last reviewed · August 23, 2026
Whose genes is NURS 6501 asking about?
The occupational detail is not scenery. A grain inspector at a farm cooperative works in the highest-conidia environment most people will ever encounter, so this case supplies both halves of the equation the assignment wants: a heavy environmental exposure and a host who cannot clear it. Say that explicitly, because the rubric rewards reasons for the symptoms rather than a restatement of them. The fever, chills and sweats are the systemic inflammatory response; the cough, pleuritic chest pain and haemoptysis are angioinvasion, which is the mechanism that distinguishes invasive aspergillosis from colonisation and from allergic bronchopulmonary disease. Hyphae invading pulmonary vessels cause infarction and haemorrhage, and that is why this patient coughs blood while a patient with an aspergilloma may not. The week-long course is itself diagnostic information: a competent host clears inhaled conidia within hours through alveolar macrophages and recruited neutrophils, so a fever persisting seven days under two immunosuppressants is a finding rather than background.
The genes question is where most submissions go wrong, and it goes wrong in a predictable way: students describe the genome of Aspergillus fumigatus. Read the wording again. The genes are the patient's, and there are two defensible directions. One is rheumatoid arthritis susceptibility, where the shared epitope alleles of HLA-DRB1 and PTPN22 are the standard answer and explain why he is on these drugs at all. The other is innate antifungal recognition, where polymorphisms in pattern-recognition receptors such as dectin-1 and the toll-like receptors have been associated with invasive aspergillosis risk in immunosuppressed cohorts. Then treat immunosuppression as two mechanisms rather than one word: methotrexate is an antimetabolite acting on folate-dependent proliferation of lymphocytes, and prednisone impairs phagocyte recruitment and macrophage killing. They suppress different arms, which is precisely why the combination lets a fungus through. They suppress different arms of the response, which is why neither drug alone would likely have let this fungus through.
Likely learning objectives
- Connect an occupational exposure to a specific opportunistic pathogen.
- Explain haemoptysis in invasive aspergillosis through angioinvasion.
- Identify host genes rather than pathogen genes when a case asks about susceptibility.
- Distinguish the immunosuppressive mechanisms of methotrexate and corticosteroids.
Assignment instructions
Read the full question
Review every instruction before using the planning guidance that follows.
Explain the process of immunosuppression and the effect it has on body systems Scenario 1: A 49-year-old patient with rheumatoid arthritis comes into the clinic with a chief complaint of a fever. Patient’s current medications include atorvastatin 40 mg at night, methotrexate 10 mg po every Friday morning and prednisone 5 mg po qam. He states that he has had a fever up to 101 degrees F for about a week and admits to chills and sweats. He says he has had more fatiguethan usual and reports some chest pain associated with coughing. He admits to having occasional episodes of hemoptysis. He works as a grain inspector at a large farm cooperative. After extensive work-up, the patient was diagnosed with Invasive aspergillosis. An understanding of cells and cell behavior is a critically important component of disease diagnosis and treatment. But some diseases can be complex in nature, with a variety of factors and circumstances impacting their emergence and severity. Effective disease analysis often requires an understanding that goes beyond isolated cell behavior. Genes, the environments in which cell processes operate, the impact of patient characteristics, and racial and ethnic variables all can have an important impact. An understanding of the signals and symptoms of alterations in cellular processes is a critical step in the diagnosis and treatment of many diseases. For APRNs, this understanding can also help educate patients and guide them through their treatment plans. In this Assignment, you examine a case study and analyze the symptoms presented. You identify a cell, gene, and/or process elements that may be factors in the diagnosis, and you explain the implications to patient health. To prepare: By Day 1 of this week, you will be assigned to a specific case study for this Case Study Assignment. Please see the “Course Announcements” section of the classroom for your assignment from your Instructor. Pathophysiology 6501 Case Study Analysis The Assignment (1- to 2-page case study analysis) Develop a 1- to 2-page case study analysis in which you: · Explain why you think the patient presented the symptoms described. · Identify the genes that may be associated with the development of the disease. · Explain the process of immunosuppression and the effect it has on body systems. Reminder: The School of Nursing requires that all papers submitted include a title page, introduction, summary, citations and references. The sample paper provided at the Walden Writing Center provides an example of those required elements (available at https://academicguides.waldenu.edu/writingcenter/templates). All papers submitted must use this formatting. RUBRIC Develop a 1- to 2-page case study analysis, examining the patient symptoms presented in the case study. Be sure to address the following: Explain why you think the patient presented the symptoms described. 28 (28%) – 30 (30%) The response accurately and thoroughly describes the patient symptoms. The response includes accurate, clear, and detailed reasons, with explanation for the symptoms supported by evidence and/or research, as appropriate, to support the explanation. 25 (25%) – 27 (27%) The response describes the patient symptoms. The response includes accurate reasons, with explanation for the symptoms supported by evidence and/or research, as appropriate, to support the explanation. 23 (23%) – 24 (24%) The response describes the patient symptoms in a manner that is vague or inaccurate. The response includes reasons for the symptoms, with explanations that are vague or based on inappropriate evidence/research. 0 (0%) – 22 (22%) The response describes the patient symptoms in a manner that is vague and inaccurate, or the description is missing. The response does not include reasons for the symptoms, or the explanations are vague or based on inappropriate or no evidence/research. Identify the genes that may be associated with the development of the disease. Pathophysiology 6501 Case Study Analysis 23 (23%) – 25 (25%) The response includes an accurate, complete, detailed, and specific analysis of the genes that may be associated with the development of the disease. 20 (20%) – 22 (22%) The response includes an accurate analysis of the genes that may be associated with the development of the disease. 18 (18%) – 19 (19%) The response includes a vague or inaccurate analysis of the genes that may be associated with the development of the disease. 0 (0%) – 17 (17%) The response includes a vague or inaccurate analysis of the genes that may be associated with the development of the disease is missing. Explain the process of immunosuppression and the effect it has on body systems. 28 (28%) – 30 (30%) The response includes an accurate, complete, detailed, and specific explanation of the pathophysiological processes that may be associated with the development of the diagnosed condition. 25 (25%) – 27 (27%) The response includes an accurate explanation of the pathophysiological processes that may be associated with the development of the diagnosed condition. 23 (23%) – 24 (24%) The response includes a vague or inaccurate explanation of the pathophysiological processes that may be associated with the development of the diagnosed condition. 0 (0%) – 17 (17%) The response includes a vague or inaccurate explanation of the pathophysiological processes that may be associated with the development of the diagnosed condition, or the analysis is missing.
What the case study analysis must contain
- 01A 1- to 2-page case study analysis.
- 02An explanation of why the patient presented the symptoms described.
- 03Identification of the genes that may be associated with the development of the disease.
- 04An explanation of the process of immunosuppression and its effect on body systems.
- 05Title page, introduction, summary, citations and references per the School of Nursing format.
Building the aspergillosis analysis in three moves
Why these symptoms, in this patient
Tie fever, chills and sweats to systemic inflammation and the pulmonary findings to invasion.
What the assessor is likely looking for
Reasons for each symptom rather than a restatement of the vignette.
The exposure that made it possible
Establish the grain cooperative as a high-burden conidial environment.
What the assessor is likely looking for
Exposure and host defect argued together, not separately.
Host genes associated with the disease
Name RA-susceptibility alleles and innate antifungal recognition polymorphisms with a rationale.
What the assessor is likely looking for
Patient genes, each tied to either the underlying disease or the infection.
Two mechanisms of immunosuppression
Separate methotrexate's antiproliferative action from prednisone's effect on phagocytes.
What the assessor is likely looking for
Different arms of immunity named for the two drugs.
Effects across body systems
Extend the immunosuppression beyond infection risk to the other systems it affects.
What the assessor is likely looking for
Systemic consequences the rubric asks for, not lung findings alone.
Where the antifungal immunity evidence sits
Recommended databases
- NCBI Bookshelf (StatPearls)
- PubMed Central
- Walden Library
- CINAHL
Search sequence
- 1.Read the aspergillosis spectrum first so you can place this case within it.
- 2.Search invasive aspergillosis together with polymorphism to find host-susceptibility work.
- 3.Look up methotrexate's mechanism separately from corticosteroid immunosuppression.
- 4.Check the adverse-effect profile of chronic low-dose prednisone across body systems.
Reference shortlist
These are authoritative starting points, not a ready-made bibliography. A qualified reviewer must confirm that each source fits the assignment and supports the claim beside which it is cited.
Aspergillosis
StatPearls, NCBI Bookshelf · 2023
The aspergillosis spectrum, for placing invasive disease against colonisation and allergic forms.
Methotrexate
StatPearls, NCBI Bookshelf · 2023
Methotrexate's antimetabolite mechanism, which is one half of the immunosuppression answer.
Corticosteroid Adverse Effects
StatPearls, NCBI Bookshelf · 2024
Corticosteroid adverse effects, including the dose-related infection risk in this patient.
Rheumatoid Arthritis
StatPearls, NCBI Bookshelf · 2023
Rheumatoid arthritis, for the HLA-DRB1 and PTPN22 susceptibility genes.
Antifungal Agents
StatPearls, NCBI Bookshelf · 2023
Antifungal agents, for the treatment context that follows from the diagnosis.
Before you submit the case analysis
Common mistakes
- Describing the Aspergillus genome when the rubric asks about the patient's genes.
- Treating methotrexate and prednisone as one undifferentiated immunosuppressant.
- Explaining the haemoptysis without naming angioinvasion.
- Ignoring the grain cooperative, which supplies the exposure half of the case.
- Listing symptoms back to the reader instead of giving reasons for them.
Submission checklist
- Have you named the occupational exposure as a risk factor?
- Is the haemoptysis explained by vascular invasion and infarction?
- Are the genes you name the patient's, with a stated reason for each?
- Have you separated the antimetabolite and corticosteroid mechanisms?
- Does the paper carry the title page, introduction, summary and references required?
Use this guide to plan and review your own work. Follow your institution's rules and read Brinevia's academic-integrity policy.
Written by
Maren Caldwell
MSN, RN, CNE
Medical-surgical nursing, pharmacology and NCLEX preparation
Maren is a registered nurse with over 15 years of clinical and educational experience in medical-surgical nursing. She writes on NCLEX preparation, patient care fundamentals, pharmacology and evidence-based practice.
Reviewed by
Dr. Tessa Redmond
DNP, RN, CNE
Evidence-based practice and clinical education
Tessa is a doctorally-prepared nurse educator. She reviews Brinevia content for clinical accuracy and alignment with current evidence-based guidelines.